Alzheimer's Association
Overview
The Alzheimer's Association is the leading voluntary health organization in Alzheimer's care, support, and research. Formed in 1980, its mission is to end Alzheimer's and all other dementias by accelerating global research, driving risk reduction, and maximizing quality care. It is the world's largest non-profit funder of Alzheimer's research, with programs like the International Research Grant Program and the Part the Cloud venture philanthropy initiative, which funds early-phase clinical trials to bridge the gap between laboratory discoveries and potential therapies. The association has over $360 million in active and committed grants across more than 1,000 projects globally. It provides funding to both academic and for-profit entities to advance promising treatments.
Portfolio Companies
6
Website
alz.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Polku Therapeutics | Jan 2025 | Grant | Co-investor |
| Priavoid | Oct 2024 | Grant | Co-investor |
| Aquinnah Pharmaceuticals | Oct 2023 | Grant | Co-investor |
| Elixiron Immunotherapeutics | Jul 2022 | Grant | Co-investor |
| Elixiron Immunotherapeutics | Aug 2020 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.